BTC
PJP icon

Bank & Trust Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bank & Trust Company’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11K Hold
60
– – ﹤0.01% 260
2026
Q1 		$6.23K Hold
60
– – ﹤0.01% 263
2025
Q4 		$6.27K Hold
60
– – ﹤0.01% 253
2025
Q3 		$5.55K Hold
60
– – ﹤0.01% 245
2025
Q2 		$4.79K Hold
60
– – ﹤0.01% 252
2025
Q1 		$5.2K Hold
60
– – ﹤0.01% 252
2024
Q4 		$4.96K Hold
60
– – ﹤0.01% 251
2024
Q3 		$5.22K Hold
60
– – ﹤0.01% 249
2024
Q2 		$4.93K Buy
+60
New +$4.77K ﹤0.01% 252

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $2.07B AUM 22.34% 1-Year Est. Return

Bank & Trust Company's PJP Position: Q2 2026 in Review

Bank & Trust Company held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 60 shares worth $7.11K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

Bank & Trust Company first reported a position in PJP in Q2 2024 and has held it in 9 quarters since. 42 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Bank & Trust Company held 60 shares of Invesco Pharmaceuticals ETF worth $7.11K as of Q2 2026.
  • Bank & Trust Company left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Bank & Trust Company's portfolio in Q2 2026, its #260 holding.
  • Bank & Trust Company first reported a position in Invesco Pharmaceuticals ETF in Q2 2024 and has held it in 9 quarters since.
  • 42 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.